21% Year-Over-Year Revenue Growth; 51% Sequential Increase in Authorization Backlog
Conference call begins at 4:30 p.m. Eastern time today
CAMBRIDGE, Mass. (May 14, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the first quarter ended March 31, 2020. Read more.